Life Line Screening: The Power of Prevention

October 26, 2017




Dr. Andrew Manganaro, Chief Medical Officer of Life Line Screening which provides affordable, convenient, community-based screening for vascular disease and related conditions joins eHealth Radio and the Health NewsVascular Disease Channels.

Listen to interview with host Eric Michaels & guest Dr. Andrew Manganaro discuss the following:

  • What do you screen for, and why these things?
  • What does community-based mean? Why is this important?
  • Can you describe one or two of the tests in more detail? For example, the carotid artery test?
  • Is your clinical staff, technicians and reviewing physicians, trained as well as hospital staff?
  • Do you offer blood tests as well? Which ones?

Dr. Andy Manganaro, MD, FACS, FACC, Chief Medical Officer and National Medical Director

Dr. Manganaro began his tenure at Life Line Screening as a physician reviewer in 2000. His commitment to the company’s overall mission motivated him to take a larger role and in 2005 he became the medical director and Chief Medical Officer, overseeing all aspects of University.clinical quality and development of clinical protocols.

He also directs Life Line Screening’s research collaborations and analysis of its unique database of more than 8 million customers. This research is shedding new light on vascular disease and vascular screening, with a recent paper on abdominal aortic aneurysm screening hailed as “groundbreaking” by those in the vascular community.

Dr. Manganaro has been a practicing vascular and cardiothoracic surgeon for more than 25 years and has cared for more than 10,000 patients with vascular disease and performed more than 5,000 vascular surgeries of every kind. Dr. Manganaro has been a tenured surgeon for more than 20 years at Kettering Hospital and was a founding member of the Governing Board of the Kettering Cardiovascular Institute of Kettering Medical Center. Dr. Manganaro is currently licensed to practice medicine in multiple states and oversees a panel of distinguished reviewing physicians.

Dr. Manganaro graduated medical school from New York University School of Medicine. He graduated Cum Laude and Phi Beta Kappa with a bachelor’s degree from Fordha.





Social Media Links:

Dr. Almeida’s International Vein Congress This April 20-22, 2017

April 4, 2017




Dr. Jose Almeida, Founder and Medical Director of the Miami Vein Center, who is a highly accomplished vascular surgeon and is known as a pioneer in Endovascular Venous Surgery joins eHealth Radio and the Health News Channnel.

Dr. Almeida is the creator and course director of the International Vein Congress, the largest educational summit dedicated to venous disease, which is now in its second decade and is taking place this year from April 20-22, 2017.


Listen to interview with host Eric Michaels & guest Dr. Jose Almeida discuss the following:

  • Can you tell us a little about the history of the International Vein Congress and why you decided to spearhead the first summit 15 years ago?
  • The IVC is made of 18 Sessions throughout the span of 3 days – each session comprises of different conversations, demonstrations and exhibits – what session are you most excited for?
  • You are known to be pretty outspoken, especially when it comes to controversial conversations, including the insurance debacle. What are your thoughts on the current state of health care in the U.S?
  • Fraud amongst doctors is another topic that you’ve been vocal about – what do you think the driving issue of this is and how can listeners avoid it?
  • Can you discuss some of IVC’s main conference learning objectives - what should attendees expect to walk away learning?  


JOSE I. ALMEIDA, MD, FACS, RPVI, RVT is a vascular surgeon in Miami, FL specializing in Endovascular Venous Surgery.
Dr. Almeida finished his general surgery residency at the University of Miami- Jackson Memorial Hospital in 1996, and vascular surgery fellowship at the University of Missouri- Columbia in 1998. From 1998-2002 he practiced at the Miami Cardiac and Vascular Institute- internationally recognized for its pioneering endovascular solutions to complex vascular problems. He then moved his focus to patients with venous disease and founded the Miami Vein Center. In 2003 he introduced the International Vein Congress (IVC) - an educational forum in venous disease management. He published the authoritative textbook “Atlas of Endovascular Venous Surgery” and is the author of numerous published peer-reviewed journal articles and textbook chapters.
Dr. Almeida is board-certified by the American Board of Surgery in both Vascular and General Surgery. He is a Fellow of the American College of Surgeons and a Voluntary Professor of Surgery at the University of Miami School of Medicine. He sits on the Board of Directors of the American Venous Forum and was elected as a Distinguished Fellow. He is chairman of the Venous Quality Committee and member of the Executive Committee and Governing Council of the Society for Vascular Surgery - Patient Safety Organization. He is sits on the Journal of Vascular Surgery: Venous and Lymphatic Editorial Board.
In 2014 he earned the distinguished Pioneers in Performance Award for North America—a biennial recognition sponsored by W. L. Gore & Associates (Gore) for physicians demonstrating an unrelenting dedication to advancing endovascular therapy.




Websites: |

Social Media Links:
Twitter: @miamiveincenter

Deep vein thrombosis with Dr. Anas Safadi

October 4, 2012


Dr. Anas Safadi, who is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology and echocardiography joins eHealth Radio. Dr. Safadi is in private practice in Northwest Indiana where his major focus has been on deep venous thrombosis.

Listen to interview [audio player below] with host Eric Michaels & guest Dr. Anas Safadi discuss the following:

  • What is a DVT also known as a deep venous thrombosis?
  • What are the symptoms of a DVT?
  • What are the risk factors associated with a DVT?
  • How is a DVT diagnosed?
  • What are the traditional methods of treating a DVT and now I understand that using an ultrasound delivery system of antico-agulation drug dissolves blood clots more completely? What's that all about? Can you describe one particular patient case where this technology was used?
  • Can a person lower their risk for a DVT? If so how.
  • How many Americans are affected each year with a DVT and why is it that 74% of Americans today have little or no awareness of DVT?
  • In your professional opinion, Dr. Safadi, should hospitals throughout the United States be making a better effort to educate patients in their communities on the dangers associated with a DVT and how do you propose they do just that?


Dr. Safadi I completed his undergraduate training at Loyola University Chicago, receiving a B. S. in biology, graduating Summa Cum Laude. He then continued his path towards becoming a physician by completing medical school at Indiana University School of Medicine. Dr. Safadi's internal medicine residency was undertaken at Indiana University as well. Following this, he completed both general cardiology and interventional cardiology fellowship at Indiana University as well. During his training, Dr. Safadi is known for publishing several abstracts and publications; most notably, in the prestigious journal, Circulation. He was awarded first place winner of the fellows in training competition at the Indiana Chapter American College of Cardiology annual meeting.

Dr. Safadi is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology and echocardiography. Dr. Safadi is in private practice in Northwest Indiana where his major focus has been on deep venous thrombosis. Dr. Safadi has devoted an immense amount of time educating others and introducing new treatment strategies for this disease process.

Contact Dr. Safadi:

ArtAssist treatment helps poor circulation with Dr. Paul van Bemmelen

September 16, 2012


Dr. Paul van Bemmelen, the developer of a device with ACI Medical to assist the arteries with the circulation called ArtAssist joins eHealth Radio and the Vascular Disease Channel. Dr. van Bemmelen is a Professor of Surgery at Temple University School of Medicine and vascular & endovascular surgeon in the Temple University Hospital in Philadelphia, PA.

Listen to interview [audio player below] with host Eric Michaels & guest Dr. Paul van Bemmelen discuss the following:

  • What does a vascular specialist do?
  • How can we stop leg-amputations from happening?
  • When should a patient seek treatment?
  • How can you improve leg-circulation?
  • You have developed a device with ACI Medical to assist the arteries with the circulation called ArtAssist: What is it and how does it work?
  • What is special about ArtAssist compared to other massage devices?
  • What can the patient expect in terms of effect?
  • Can patients buy this device?
  • What type of doctors can prescribe the ArtAssist?
  • What should listeners do, if they have poor circulation and think they might benefit from ArtAssist treatment?


Paul S. van Bemmelen, MD, PhD, FACS attended medical school at the University of Leiden in the Netherlands. He then completed fellowships in open and endovascular surgery at the University of Washington (Seattle, WA), St. Anthonius Hospital (Nieuwegein, Netherlands), and Southern Illinois University (Springfield, IL). He has been in practice since 1993.

He obtained patents for the first arterial assist device in 1993. Because he used the earliest prototype devices, Dr. van Bemmelen has the longest clinical experience with the use of ArtAssist® devices in the world. In addition to the initial studies with ultrasound, he used laser-Doppler, angiographic and other studies to increase the scientific knowledge about the compression method and its application in patients with peripheral arterial disease.

Dr. van Bemmelen’s previous positions include Associate Professor at State University of New York and Chief of Vascular Surgery at the VA Medical Center in Northport, NY.

Dr. van Bemmelen is currently Professor of Surgery at Temple University School of Medicine and a vascular and endovascular surgeon at Temple University Hospital in Philadelphia, PA, where he consults arterio-venous disease patients for both surgical and non-invasive treatments.


Specialty areas:  Non-reconstructable diabetic limb salvage, intermittent compression treatment for PVD, carotid endarterectomy, aortic surgery, cosmetic treatment for varicose veins including sclerotherapy

Certifications:  Vascular surgery, general surgery


Related Web Sites: |

EKOS system better than traditional use of clot-buster medications with Dr. Keith Sterling

September 6, 2012


Dr. Keith M. Sterling joins eHealth Radio to discuss pulmonary embolisms and how the  EKOS system is better than traditional use of clot-buster medications. Dr. Sterling who has been on the medical staff of Inova Alexandria Hospital since 1995.

Listen to interview [audio player below] with host Eric Michaels & guest Dr. Keith Sterling discuss the following:

  • Dr. Sterling, what is a pulmonary embolism?
  • You have clearly described a pulmonary embolism but our listening audience needs to understand risk factors in developing a pulmonary embolism.
  • How is a pulmonary embolism traditionally treated?
  • From what I understand, there is a better and new interventional approach to dissolving a blood clot or clots that is showing remarkable outcomes.  What would that be?
  • Dr. Sterling, what makes the EKOS system better than the traditional use of clot-buster medications?
  • Can you describe a recent patient case where you used EKOS?
  • What are the typical patient outcomes for patients who are treated with EKOS technology?
  • Can you offer advice to our listeners regarding how they can reduce their risks of developing a PE?


Dr. Keith M. Sterling has been on the medical staff of Inova Alexandria Hospital since 1995. He earned his medical degree from New York Medical College and completed both an internal medicine internship through Columbia University College of Physicians & Surgeons, and a diagnostic radiology residency at Mount Sinai Medical Center in New York, where he was chief resident.

He went on to a fellowship in vascular and interventional radiology at the Washington University School of Medicine, Mallinckrodt Institute of Radiology, in St. Louis.

Dr. Sterling is board certified in Diagnostic Radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology. He is the Medical Director of the Department of Cardiovascular & Interventional Radiology and has been the principal investigator on numerous interventional drug and device research projects. He has served as President of the Chesapeake Interventional Radiology Society and is a frequently invited lecturer at numerous scientific meetings.


Related Web Site:

How vascular procedures should or should not be done at the VEITHsymposium

August 28, 2012


Dr. Frank J. Veith, Professor of Surgery and the William J. von Liebig Chair in Vascular Surgery at the Cleveland Clinic and Professor of Surgery at New York University Medical Center join eHealth Radio. Dr. Veith is the chairman of the VEITHsymposium, the largest medical symposia in the world attended by vascular surgeons and interventionalists. VEITHsymposium is now in it's 39th year in New York City.

Listen to interview [audio player below] with host Eric Michaels & guest Dr. Frank J. Veith discuss the following:

  • Dr. Veith, you started your career with a strong interest in treating patients with vascular disease.  You are known for limb salvaging and one of the first in the globe to perform the first endovascular procedures for abdominal aortic aneurysms. For our listening audience, what is the role of a vascular surgeon?
  • What are the types of diseases and conditions vascular surgeons typically treat?
  • What is new and on the horizon in the field of vascular surgery?
  • You have had an enormous career, traveling globally lecturing to many vascular surgeons and specialists, especially in developing countries, giving them your time, energy and opinions relative to how vascular procedures should or should not be done.  Care to elaborate?
  • What was the inspiration and motivation that engaged you to develop and write a vascular surgery program, known as  VEITHsymposium, (now in it's 39th year) where you have served as Chairman of the largest international vascular surgery program in the world?
  • How does a program like the VEITHsymposium benefit it's attendees and who exactly should attend this meeting?
  • How does VEITHsymposium benefit the public?
  • What are your biggest concerns today regarding vascular surgery, in particular having to do with unnecessary procedures? Will you be addressing this at this years VEITHsymposium?
  • What are your concerns or positives on Obamacare and it's impact on vascular surgery if any?
  • Your final concluding comments about its negative effects on the medical device industry?


Dr. Veith graduated from Cornell University Medical School with Honors before completing an internship at Columbia-Presbyterian Hospital in New York and his surgical residency training at Peter Bent Brigham Hospital and Harvard Medical School. Dr. Veith achieved success with his pioneering work in experimental and clinical lung transplantation. In the 1970s and 1980s, Dr. Veith's attention turned toward Vascular Surgery with an emphasis on lower extremity revascularization procedures. He and his colleagues were the first to advocate an aggressive approach to saving limbs threatened by arteriosclerosis and gangrene when most patients with this problem were being treated by a major amputation.

In the late 1980s and early1990s Dr. Veith became increasingly involved with endovascular treatments. He and his group were the first to perform an endovascular graft repair of an abdominal aortic aneurysm or EVAR in the United States. They also were the first in the world to perform an EVAR for a ruptured abdominal aneurysm.

Dr. Veith has held positions in every national vascular society and many international ones. In 1995 he was elected President of the Society for Vascular Surgery, the most prestigious society in the field. He has been a leading advocate for the recognition of Vascular Surgery as a separate and distinct specialty and is a past Chairman of the American Board of Vascular Surgery.

Dr. Veith held positions as Chief of Vascular Surgery and Interim Chairman of Surgery at Montefiore Medical Center and Albert Einstein College of Medicine for many years. In the last five, he was The William J. Von Liebig Chair in Vascular Surgery and the Vice Chairman of the Department of Surgery. Throughout his career he has received numerous awards and honors as a leader, outstanding teacher and innovator in Vascular Surgery.

He is now Professor of Surgery and The William J. von Liebig Chair in Vascular Surgery at the Cleveland Clinic and Professor of Surgery at New York University Medical Center. As he has done for many years, Dr. Veith also chairs the largest Vascular Surgery meeting, the VEITHsymposium, held annually in New York City.

Specialty areas: Endovascular Surgery, Limb Salvage Surgery, Endovascular Aneurysm Repair EVAR, Carotid Stenting vs. Carotid Endarterectomy, Vascular Surgery as a Separate and Distinct Specialty.


Related Web Site: